Characteristic | N (%) or median (IQR) |
Age (years) | 67 (55–76) |
Gender, male | 145 (46.8) |
Hypertension | 246 (79.4) |
Dyslipidaemia | 116 (37.4) |
Atrial fibrillation | 94 (30.3) |
Diabetes | 82 (26.5) |
Smoking | 63 (20.3) |
Glucose | 122 (103–151) |
Baseline SBP | 150 (130–175) |
Baseline NIHSS | 17 (14–21) |
e-ASPECTS | 8 (7-9) |
CTP core (CBF <30%) | 6.6 (0–23.75) |
IV t-PA | 47 (15.2) |
Occlusion site | |
ACA | 2 (0.6%) |
Extracranial ICA | 12 (3.9%) |
Intracranial ICA | 51 (16.5%) |
MCA-M1 | 154 (49.7%) |
MCA-M2 | 45 (14.5%) |
MCA-M3 | 7 (2.3%) |
Tandem occlusion* | 39 (12.6%) |
Time from LWN to arterial puncture (min) | 645(478–900) |
mTICI (2b-3) | 300 (96.8) |
Any PH | 31 (10) |
90-day mRS 0–2† | 102 (40.2) |
90-day mortality† | 63 (24.8) |
*Intracranial occlusion site: ICA-T: 15/39 (38.5%), MCA-M1: 19/39 (48.7%) and MCA-M2: 5/39 (12.8%).
†n=254.
ACA, anterior cerebral artery; ASPECTS, Alberta Stroke Program Early CT Score; CBF, cerebral blood flow; CTP, CT perfusion; ICA, internal carotid artery; LKN, Last Known Normal; NIHSS, baseline National Institute of Health Stroke Scale; PH, parenchymal haematoma; SBP, systolic blood pressure.